AFLAC Incorporated (AFL) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

AFLAC Incorporated

NYSE•Financial Services•Insurance - Life

$116.60-0.21(<0.01%)After hours

Market Cap

$58.78B

P/E

12.1x

P/S

3.3x

P/B

1.9x

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

How this company scores

GoodMetricSide Score: 76/100

Strongest: Profitability (22/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability22/25

Growth22/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality17/25

Strengths

Strong marginsHigh ROERising earningsInterest easily covered

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 12.1x5y range 10.5x – 23.2x

Currently near its 20-quarter median.

P/S · 3.3x5y range 3.0x – 3.6x

Currently near its 20-quarter median.

P/B · 1.9x5y range 1.9x – 3.4x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Earnings Quality

Red Flag

FCF consistently trails net income (avg 1.2x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $58.78B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $18.07B
Q. Revenue: $4.12B
TTM EBITDA: $5.70B
TTM Op. Income: $5.66B
Q. Op. Income: $961.00M
TTM Net Income: $4.86B
Q. Net Income: $825.00M
EPS: $1.64
Shares Out.: $504.12M

$18.07B in TTM revenue grew 13.6% YoY, reaching $4.12B last quarter. TTM EBITDA of $5.70B and TTM operating income of $5.66B show growth is flowing through to the bottom line. TTM net income of $4.86B means revenue is converting into profit. Over the past year, TTM revenue is up 14% — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 23.5%
Op. Margin: 23.3%
Net Margin: 20.0%

Op. margin of 23.3% is up 4.3% YoY — cost efficiency is improving. Net margin at 20.0% Across the last 8 quarters, operating margin has fallen for 3 consecutive quarters — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 12.1x
P/S Ratio: 3.3x
P/B Ratio: 1.9x

At 12.1x P/E, the stock trades below typical market levels. P/S of 3.3x and P/B of 1.9x provide additional context. P/E sits below typical market levels while revenue is growing. Over the past year, P/E is down 48% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $115.96B
Cash: $6.12B
Long-Term Debt: N/A
Book Value: $30.31B
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $112.00M
TTM Free Cash Flow: $2.65B
FCF Margin: 14.6%
FCF / Net Income: 0.5

TTM FCF of $2.65B on $112.00M in operating cash flow. The FCF / Net Income ratio of 0.5x means cash covers only part of net income — earnings quality needs attention. Over the past year, free cash flow is up 2% — a weakening trend.